Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06530186 · ClinicalTrials.gov registry record · NA
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
A NA study, sponsored by Atlantic Health System.
- Not yet
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT06530186 is a NA study that has not yet begun recruiting, run by Atlantic Health System. The registered enrollment target is 1,000 participants.
The verdict
NCT06530186, a NA study, has not yet begun recruiting, sponsored by Atlantic Health System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.
Interventions
- DEVICE LiviWell Postcoital Vaginal Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06530186
The ClinicalTrials.gov registry entry for NCT06530186 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LiviWell Postcoital Vaginal Insert is the first listed.
NCT06530186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06530186 about?
NCT06530186 is a clinical study titled "Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters". LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Li...
What is the current status of trial NCT06530186?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-08-01. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT06530186?
The interventions under investigation include: LiviWell Postcoital Vaginal Insert (DEVICE).
Who is sponsoring clinical trial NCT06530186?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.